Rather than viewing peak-effect days as a setback, many PlexusDx patients recognize them as proof the medication is working
Injectable semaglutide generally has limited clinical impact on most oral drugs, but patients starting insulin, sulfonylureas, or other diabetes medications require careful dose adjustments to prevent hypoglycemia
Red light reaches the dermis where fibroblasts produce collagen
During this adjustment window, some patients experience increased appetite, slight weight regain, or temporary blood sugar fluctuations as insulin sensitivity normalizes
Some begin a tapering plan toward a lower maintenance dose
Medical Writing and Editorial Assistance Editorial and medical writing services in the preparation of this manuscript were provided by Angela Stocks, PhD, of Larix A/S, Copenhagen, Denmark